

NCT02788045 comparison:

Summary:
CHIA has 10 criteria while your personal folder has 10 criteria
Total found criteria: 10/10
Total not Found: 0/10
Total Extra: 2
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Are negative for human immunodeficiency virus      │ Are negative for human immunodeficiency virus      │
│ (HIV) infection at screening                       │ (HIV) infection at screening                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Is healthy on the basis of physical examination,   │ Is healthy on the basis of physical examination,   │
│ medical history, electrocardiogram (ECG), and      │ medical history, electrocardiogram (ECG), and      │
│ vital signs measurement performed at screening     │ vital signs measurement performed at screening     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Are willing/able to adhere to the prohibitions and │ Are willing/able to adhere to the prohibitions and │
│ restrictions specified in the protocol and study   │ restrictions specified in the protocol and study   │
│ procedures                                         │ procedures                                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Female participants of childbearing potential must │ Female participants of childbearing potential must │
│ have a negative serum pregnancy test (beta human   │ have a negative serum pregnancy test (beta human   │
│ chorionic gonadotropin [beta hCG]) at the          │ chorionic gonadotropin \[beta hCG\]) at the        │
│ Screening visit, and a negative urine pregnancy    │ Screening visit, and a negative urine pregnancy    │
│ test pre-dose on Day 1                             │ test pre-dose on Day 1                             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Are assessed by the clinic staff as being at low   │ Are assessed by the clinic staff as being at low   │
│ risk for HIV infection                             │ risk for HIV infection                             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Has chronic hepatitis B (measured by hepatitis B   │ Has chronic hepatitis B (measured by hepatitis B   │
│ surface antigen test) or active hepatitis C        │ surface antigen test) or active hepatitis C        │
│ (measured by hepatitis C virus [HCV] Ab test; if   │ (measured by hepatitis C virus \[HCV\] Ab test; if │
│ positive, HCV ribonucleic acid [RNA] PCR test will │ positive, HCV ribonucleic acid \[RNA\] PCR test    │
│ be used to confirm active versus past HCV          │ will be used to confirm active versus past HCV     │
│ infection), active syphilis infection, chlamydia,  │ infection), active syphilis infection, chlamydia,  │
│ gonorrhea, or trichomonas . Active syphilis        │ gonorrhea, or trichomonas . Active syphilis        │
│ documented by serology unless positive serology is │ documented by serology unless positive serology is │
│ due to past treated infection                      │ due to past treated infection                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Has had a thyroidectomy or active thyroid disease  │ Has had a thyroidectomy or active thyroid disease  │
│ requiring medication during the last 12 months     │ requiring medication during the last 12 months     │
│ (not excluded: a stable thyroid supplementation)   │ (not excluded: a stable thyroid supplementation)   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Has had major psychiatric illness and/or substance │ Has had major psychiatric illness and/or substance │
│ abuse problems during the past 12 months           │ abuse problems during the past 12 months           │
│ (including hospitalization or periods of work      │ (including hospitalization or periods of work      │
│ disability) that in the opinion of the             │ disability) that in the opinion of the             │
│ investigator would preclude participation          │ investigator would preclude participation          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Has been in receipt of any licensed vaccine within │ Has been in receipt of any licensed vaccine within │
│ 14 days prior to the first dose of study           │ 14 days prior to the first dose of study           │
│ vaccine/placebo, plans to receive within 14 days   │ vaccine/placebo, plans to receive within 14 days   │
│ after the first study vaccination, or plans to     │ after the first study vaccination, or plans to     │
│ receive within 14 days before or after the second, │ receive within 14 days before or after the second, │
│ third or fourth vaccination                        │ third or fourth vaccination                        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Is a recipient of a prophylactic or therapeutic    │ Is a recipient of a prophylactic or therapeutic    │
│ HIV vaccine candidate at any time, or a recipient  │ HIV vaccine candidate at any time, or a recipient  │
│ of other experimental vaccine(s) within the last   │ of other experimental vaccine(s) within the last   │
│ 12 months. For participants who received an        │ 12 months prior to the Day 1 visit (Vaccination    │
│ experimental vaccine (except HIV vaccine) more     │ 1). For participants who received an experimental  │
│ than 12 months ago, documentation of the identity  │ vaccine (except HIV vaccine) more than 12 months   │
│ of the experimental vaccine must be provided to    │ prior to the Day 1 visit (Vaccination 1),          │
│ the sponsor, who will determine eligibility on a   │ documentation of the identity of the experimental  │
│ case-by-case basis                                 │ vaccine must be provided to the sponsor, who will  │
│                                                    │ determine eligibility on a case-by-case basis      │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒═══════════════════════════════════╕
│ Extra Personal Criteria           │
╞═══════════════════════════════════╡
│ Must have minimum age of 18 Years │
├───────────────────────────────────┤
│ Must have maximum age of 50 Years │
╘═══════════════════════════════════╛